Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow

Background: Linezolid, bedaquiline, and newer fluoroquinolones are currently placed as priority Group A drugs for the treatment of drug-resistant tuberculosis. The number of reported linezolid-resistant clinical strains is still low, and the correlation of molecular determinants with phenotype is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ushtanit, Anastasia, Mikhailova, Yulia, Lyubimova, Alexandra, Makarova, Marina, Safonova, Svetlana, Filippov, Alexey, Borisov, Sergey, Zimenkov, Danila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532644/
https://www.ncbi.nlm.nih.gov/pubmed/34680823
http://dx.doi.org/10.3390/antibiotics10101243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532644/
https://www.ncbi.nlm.nih.gov/pubmed/34680823
http://dx.doi.org/10.3390/antibiotics10101243

Ejemplares similares